10 20 30 40 50 60 70 80 2CBQ - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER ANTIMICROBIAL 06-JAN-06 2CBQ
TITLE CRYSTAL STRUCTURE OF THE NEOCARZINOSTATIN 1TES15 MUTANT TITLE 2 BOUND TO TESTOSTERONE HEMISUCCINATE.
COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEOCARZINOSTATIN; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: RESIDUES 35-147; COMPND 5 SYNONYM: NCS, MITOMALCIN, MMC; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES CARZINOSTATICUS; SOURCE 3 ORGANISM_TAXID: 1897; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BLR(DE3) PLYSS
KEYWDS ANTIBIOTIC, ANTIMICROBIAL, DNA-BINDING, PHAGE-DISPLAY KEYWDS 2 HAPTEN BINDING
EXPDTA X-RAY DIFFRACTION
AUTHOR A.DREVELLE,M.GRAILLE,B.HEYD,I.SOREL,N.ULRYCK,F.PECORARI, AUTHOR 2 M.DESMADRIL,H.VAN TILBEURGH,P.MINARD
REVDAT 3 24-FEB-09 2CBQ 1 VERSN REVDAT 2 26-APR-06 2CBQ 1 JRNL REVDAT 1 22-MAR-06 2CBQ 0
JRNL AUTH A.DREVELLE,M.GRAILLE,B.HEYD,I.SOREL,N.ULRYCK, JRNL AUTH 2 F.PECORARI,M.DESMADRIL,H.VAN TILBEURGH,P.MINARD JRNL TITL STRUCTURES OF IN VITRO EVOLVED BINDING SITES ON JRNL TITL 2 NEOCARZINOSTATIN SCAFFOLD REVEAL UNANTICIPATED JRNL TITL 3 EVOLUTIONARY PATHWAYS. JRNL REF J.MOL.BIOL. V. 358 455 2006 JRNL REFN ISSN 0022-2836 JRNL PMID 16529771 JRNL DOI 10.1016/J.JMB.2006.02.002
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.HEYD,F.PECORARI,B.COLLINET,E.ADJADJ,M.DESMADRIL, REMARK 1 AUTH 2 P.MINARD REMARK 1 TITL IN VITRO EVOLUTION OF THE BINDING SPECIFICITY OF REMARK 1 TITL 2 NEOCARZINOSTATIN, AN ENEDIYNE-BINDING REMARK 1 TITL 3 CHROMOPROTEIN. REMARK 1 REF BIOCHEMISTRY V. 42 5674 2003 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 12741824 REMARK 1 DOI 10.1021/BI0273664
REMARK 2 REMARK 2 RESOLUTION. 2.6 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.6 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.0 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 94.6 REMARK 3 NUMBER OF REFLECTIONS : 20163 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.2071 REMARK 3 FREE R VALUE : 0.2565 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.6 REMARK 3 FREE R VALUE TEST SET COUNT : 984 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4680 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 249 REMARK 3 SOLVENT ATOMS : 87 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.656 REMARK 3 B22 (A**2) : -2.923 REMARK 3 B33 (A**2) : 6.580 REMARK 3 B12 (A**2) : 0.000 REMARK 3 B13 (A**2) : 0.000 REMARK 3 B23 (A**2) : 0.000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008261 REMARK 3 BOND ANGLES (DEGREES) : 1.40747 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.360637 REMARK 3 BSOL : 26.6769 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : THS.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : THS.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2CBQ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JAN-06. REMARK 100 THE PDBE ID CODE IS EBI-27095.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM30A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19074 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.5 REMARK 200 DATA REDUNDANCY : 1.970 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.4 REMARK 200 DATA REDUNDANCY IN SHELL : 1.98 REMARK 200 R MERGE FOR SHELL (I) : 0.45000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1NCO REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.48800 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.63400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 48.91350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 64.63400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.48800 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 48.91350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 400 REMARK 400 COMPOUND REMARK 400 HAS ANTIBIOTIC ACTIVITY FOR GRAM-POSITIVE BACTERIA REMARK 400 AND ANTITUMOR ACTIVITY FOR CERTAIN MOUSE TUMORS. REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASP 67 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLY 69 TO TYR REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 71 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN A, TRP 73 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN A, LEU 79 TO HIS REMARK 400 ENGINEERED RESIDUE IN CHAIN A, CYS 81 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PHE 86 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASP 67 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN B, GLY 69 TO TYR REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 71 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN B, TRP 73 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, LEU 79 TO HIS REMARK 400 ENGINEERED RESIDUE IN CHAIN B, CYS 81 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN B, PHE 86 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN C, ASP 67 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN C, GLY 69 TO TYR REMARK 400 ENGINEERED RESIDUE IN CHAIN C, CYS 71 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN C, TRP 73 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN C, LEU 79 TO HIS REMARK 400 ENGINEERED RESIDUE IN CHAIN C, CYS 81 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN C, PHE 86 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN D, ASP 67 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN D, GLY 69 TO TYR REMARK 400 ENGINEERED RESIDUE IN CHAIN D, CYS 71 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN D, TRP 73 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN D, LEU 79 TO HIS REMARK 400 ENGINEERED RESIDUE IN CHAIN D, CYS 81 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN D, PHE 86 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN E, ASP 67 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN E, GLY 69 TO TYR REMARK 400 ENGINEERED RESIDUE IN CHAIN E, CYS 71 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN E, TRP 73 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN E, LEU 79 TO HIS REMARK 400 ENGINEERED RESIDUE IN CHAIN E, CYS 81 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN E, PHE 86 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN F, ASP 67 TO TRP REMARK 400 ENGINEERED RESIDUE IN CHAIN F, GLY 69 TO TYR REMARK 400 ENGINEERED RESIDUE IN CHAIN F, CYS 71 TO ARG REMARK 400 ENGINEERED RESIDUE IN CHAIN F, TRP 73 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN F, LEU 79 TO HIS REMARK 400 ENGINEERED RESIDUE IN CHAIN F, CYS 81 TO SER REMARK 400 ENGINEERED RESIDUE IN CHAIN F, PHE 86 TO LEU
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 ASN A 113 REMARK 465 HIS A 114 REMARK 465 ALA B 1 REMARK 465 ALA C 1 REMARK 465 HIS C 114 REMARK 465 ALA D 1 REMARK 465 HIS D 114 REMARK 465 ALA E 1 REMARK 465 HIS E 114 REMARK 465 ALA F 1 REMARK 465 ASN F 113 REMARK 465 HIS F 114
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASN C 113 OD1 - CG - ND2 ANGL. DEV. = -15.8 DEGREES REMARK 500 ASN D 113 OD1 - CG - ND2 ANGL. DEV. = -15.8 DEGREES REMARK 500 ASN E 113 OD1 - CG - ND2 ANGL. DEV. = -15.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 52 162.52 -48.29 REMARK 500 ASP B 41 153.90 171.51 REMARK 500 ALA B 92 81.58 -68.72 REMARK 500 ALA C 63 147.51 176.89 REMARK 500 PRO C 105 -176.23 -67.03 REMARK 500 ALA E 63 146.68 -179.78 REMARK 500 PRO F 105 177.03 -57.15 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE):
REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED.
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1113 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B1115 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C1114 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 E1114 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 F1113 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH2 A1114 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH2 A1115 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH2 B1116 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH2 B1117 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH2 C1115 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH2 D1114 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH2 E1115 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TH2 F1114
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1J5H RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF APO-NEOCARZINOSTATIN REMARK 900 RELATED ID: 1J5I RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF A NOVEL CHROMOPROTEIN REMARK 900 DERIVED FROMAPO-NEOCARZINOSTATIN AND A REMARK 900 SYNTHETIC CHROMOPHORE REMARK 900 RELATED ID: 1KVH RELATED DB: PDB REMARK 900 NCSI-GB-BULGE-DNA COMPLEX INDUCED FORMATION REMARK 900 OF A DNA BULGESTRUCTURE BY A MOLECULAR REMARK 900 WEDGE LIGAND-POST-ACTIVATEDNEOCARZINOSTATIN REMARK 900 CHROMOPHORE REMARK 900 RELATED ID: 1MP7 RELATED DB: PDB REMARK 900 A THIRD COMPLEX OF POST-ACTIVATED REMARK 900 NEOCARZINOSTATINCHROMOPHORE WITH DNA. BULGE DNA REMARK 900 BINDING FROM THE MINORGROOVE REMARK 900 RELATED ID: 1NCO RELATED DB: PDB REMARK 900 HOLO-NEOCARZINOSTATIN (CONTAINING CHROMOPHORE) REMARK 900 COMPLEX WITH APO-CARZINOSTATIN (CONTAINING MPD) REMARK 900 RELATED ID: 1NOA RELATED DB: PDB REMARK 900 NEOCARZINOSTATIN REMARK 900 RELATED ID: 1O5P RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF HOLO-NEOCARZINOSTATIN REMARK 900 RELATED ID: 2CBM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE APO-FORM OF A REMARK 900 NEOCARZINOSTATIN MUTANT EVOLVED TO BIND REMARK 900 TESTOSTERONE. REMARK 900 RELATED ID: 2CBO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE NEOCARZINOSTATIN REMARK 900 3TES24 MUTANT BOUND TO TESTOSTERONE REMARK 900 HEMISUCCINATE. REMARK 900 RELATED ID: 2CBT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE NEOCARZINOSTATIN REMARK 900 4TES1 MUTANT BOUND TESTOSTERONE HEMISUCCINATE.
DBREF 2CBQ A 1 113 UNP P0A3R9 NCZS_STRCZ 35 147 DBREF 2CBQ A 114 114 PDB 2CBQ 2CBQ 114 114 DBREF 2CBQ B 1 113 UNP P0A3R9 NCZS_STRCZ 35 147 DBREF 2CBQ B 114 114 PDB 2CBQ 2CBQ 114 114 DBREF 2CBQ C 1 113 UNP P0A3R9 NCZS_STRCZ 35 147 DBREF 2CBQ C 114 114 PDB 2CBQ 2CBQ 114 114 DBREF 2CBQ D 1 113 UNP P0A3R9 NCZS_STRCZ 35 147 DBREF 2CBQ D 114 114 PDB 2CBQ 2CBQ 114 114 DBREF 2CBQ E 1 113 UNP P0A3R9 NCZS_STRCZ 35 147 DBREF 2CBQ E 114 114 PDB 2CBQ 2CBQ 114 114 DBREF 2CBQ F 1 113 UNP P0A3R9 NCZS_STRCZ 35 147 DBREF 2CBQ F 114 114 PDB 2CBQ 2CBQ 114 114
SEQADV 2CBQ TRP A 33 UNP P0A3R9 ASP 67 ENGINEERED MUTATION SEQADV 2CBQ TYR A 35 UNP P0A3R9 GLY 69 ENGINEERED MUTATION SEQADV 2CBQ ARG A 37 UNP P0A3R9 CYS 71 ENGINEERED MUTATION SEQADV 2CBQ ALA A 39 UNP P0A3R9 TRP 73 ENGINEERED MUTATION SEQADV 2CBQ HIS A 45 UNP P0A3R9 LEU 79 ENGINEERED MUTATION SEQADV 2CBQ SER A 47 UNP P0A3R9 CYS 81 ENGINEERED MUTATION SEQADV 2CBQ LEU A 52 UNP P0A3R9 PHE 86 ENGINEERED MUTATION SEQADV 2CBQ TRP B 33 UNP P0A3R9 ASP 67 ENGINEERED MUTATION SEQADV 2CBQ TYR B 35 UNP P0A3R9 GLY 69 ENGINEERED MUTATION SEQADV 2CBQ ARG B 37 UNP P0A3R9 CYS 71 ENGINEERED MUTATION SEQADV 2CBQ ALA B 39 UNP P0A3R9 TRP 73 ENGINEERED MUTATION SEQADV 2CBQ HIS B 45 UNP P0A3R9 LEU 79 ENGINEERED MUTATION SEQADV 2CBQ SER B 47 UNP P0A3R9 CYS 81 ENGINEERED MUTATION SEQADV 2CBQ LEU B 52 UNP P0A3R9 PHE 86 ENGINEERED MUTATION SEQADV 2CBQ TRP C 33 UNP P0A3R9 ASP 67 ENGINEERED MUTATION SEQADV 2CBQ TYR C 35 UNP P0A3R9 GLY 69 ENGINEERED MUTATION SEQADV 2CBQ ARG C 37 UNP P0A3R9 CYS 71 ENGINEERED MUTATION SEQADV 2CBQ ALA C 39 UNP P0A3R9 TRP 73 ENGINEERED MUTATION SEQADV 2CBQ HIS C 45 UNP P0A3R9 LEU 79 ENGINEERED MUTATION SEQADV 2CBQ SER C 47 UNP P0A3R9 CYS 81 ENGINEERED MUTATION SEQADV 2CBQ LEU C 52 UNP P0A3R9 PHE 86 ENGINEERED MUTATION SEQADV 2CBQ TRP D 33 UNP P0A3R9 ASP 67 ENGINEERED MUTATION SEQADV 2CBQ TYR D 35 UNP P0A3R9 GLY 69 ENGINEERED MUTATION SEQADV 2CBQ ARG D 37 UNP P0A3R9 CYS 71 ENGINEERED MUTATION SEQADV 2CBQ ALA D 39 UNP P0A3R9 TRP 73 ENGINEERED MUTATION SEQADV 2CBQ HIS D 45 UNP P0A3R9 LEU 79 ENGINEERED MUTATION SEQADV 2CBQ SER D 47 UNP P0A3R9 CYS 81 ENGINEERED MUTATION SEQADV 2CBQ LEU D 52 UNP P0A3R9 PHE 86 ENGINEERED MUTATION SEQADV 2CBQ TRP E 33 UNP P0A3R9 ASP 67 ENGINEERED MUTATION SEQADV 2CBQ TYR E 35 UNP P0A3R9 GLY 69 ENGINEERED MUTATION SEQADV 2CBQ ARG E 37 UNP P0A3R9 CYS 71 ENGINEERED MUTATION SEQADV 2CBQ ALA E 39 UNP P0A3R9 TRP 73 ENGINEERED MUTATION SEQADV 2CBQ HIS E 45 UNP P0A3R9 LEU 79 ENGINEERED MUTATION SEQADV 2CBQ SER E 47 UNP P0A3R9 CYS 81 ENGINEERED MUTATION SEQADV 2CBQ LEU E 52 UNP P0A3R9 PHE 86 ENGINEERED MUTATION SEQADV 2CBQ TRP F 33 UNP P0A3R9 ASP 67 ENGINEERED MUTATION SEQADV 2CBQ TYR F 35 UNP P0A3R9 GLY 69 ENGINEERED MUTATION SEQADV 2CBQ ARG F 37 UNP P0A3R9 CYS 71 ENGINEERED MUTATION SEQADV 2CBQ ALA F 39 UNP P0A3R9 TRP 73 ENGINEERED MUTATION SEQADV 2CBQ HIS F 45 UNP P0A3R9 LEU 79 ENGINEERED MUTATION SEQADV 2CBQ SER F 47 UNP P0A3R9 CYS 81 ENGINEERED MUTATION SEQADV 2CBQ LEU F 52 UNP P0A3R9 PHE 86 ENGINEERED MUTATION
SEQRES 1 A 114 ALA ALA PRO THR ALA THR VAL THR PRO SER SER GLY LEU SEQRES 2 A 114 SER ASP GLY THR VAL VAL LYS VAL ALA GLY ALA GLY LEU SEQRES 3 A 114 GLN ALA GLY THR ALA TYR TRP VAL TYR GLN ARG ALA ALA SEQRES 4 A 114 VAL ASP THR GLY VAL HIS ALA SER ASN PRO ALA ASP LEU SEQRES 5 A 114 SER SER VAL THR ALA ASP ALA ASN GLY SER ALA SER THR SEQRES 6 A 114 SER LEU THR VAL ARG ARG SER PHE GLU GLY PHE LEU PHE SEQRES 7 A 114 ASP GLY THR ARG TRP GLY THR VAL ASP CYS THR THR ALA SEQRES 8 A 114 ALA CYS GLN VAL GLY LEU SER ASP ALA ALA GLY ASN GLY SEQRES 9 A 114 PRO GLU GLY VAL ALA ILE SER PHE ASN HIS SEQRES 1 B 114 ALA ALA PRO THR ALA THR VAL THR PRO SER SER GLY LEU SEQRES 2 B 114 SER ASP GLY THR VAL VAL LYS VAL ALA GLY ALA GLY LEU SEQRES 3 B 114 GLN ALA GLY THR ALA TYR TRP VAL TYR GLN ARG ALA ALA SEQRES 4 B 114 VAL ASP THR GLY VAL HIS ALA SER ASN PRO ALA ASP LEU SEQRES 5 B 114 SER SER VAL THR ALA ASP ALA ASN GLY SER ALA SER THR SEQRES 6 B 114 SER LEU THR VAL ARG ARG SER PHE GLU GLY PHE LEU PHE SEQRES 7 B 114 ASP GLY THR ARG TRP GLY THR VAL ASP CYS THR THR ALA SEQRES 8 B 114 ALA CYS GLN VAL GLY LEU SER ASP ALA ALA GLY ASN GLY SEQRES 9 B 114 PRO GLU GLY VAL ALA ILE SER PHE ASN HIS SEQRES 1 C 114 ALA ALA PRO THR ALA THR VAL THR PRO SER SER GLY LEU SEQRES 2 C 114 SER ASP GLY THR VAL VAL LYS VAL ALA GLY ALA GLY LEU SEQRES 3 C 114 GLN ALA GLY THR ALA TYR TRP VAL TYR GLN ARG ALA ALA SEQRES 4 C 114 VAL ASP THR GLY VAL HIS ALA SER ASN PRO ALA ASP LEU SEQRES 5 C 114 SER SER VAL THR ALA ASP ALA ASN GLY SER ALA SER THR SEQRES 6 C 114 SER LEU THR VAL ARG ARG SER PHE GLU GLY PHE LEU PHE SEQRES 7 C 114 ASP GLY THR ARG TRP GLY THR VAL ASP CYS THR THR ALA SEQRES 8 C 114 ALA CYS GLN VAL GLY LEU SER ASP ALA ALA GLY ASN GLY SEQRES 9 C 114 PRO GLU GLY VAL ALA ILE SER PHE ASN HIS SEQRES 1 D 114 ALA ALA PRO THR ALA THR VAL THR PRO SER SER GLY LEU SEQRES 2 D 114 SER ASP GLY THR VAL VAL LYS VAL ALA GLY ALA GLY LEU SEQRES 3 D 114 GLN ALA GLY THR ALA TYR TRP VAL TYR GLN ARG ALA ALA SEQRES 4 D 114 VAL ASP THR GLY VAL HIS ALA SER ASN PRO ALA ASP LEU SEQRES 5 D 114 SER SER VAL THR ALA ASP ALA ASN GLY SER ALA SER THR SEQRES 6 D 114 SER LEU THR VAL ARG ARG SER PHE GLU GLY PHE LEU PHE SEQRES 7 D 114 ASP GLY THR ARG TRP GLY THR VAL ASP CYS THR THR ALA SEQRES 8 D 114 ALA CYS GLN VAL GLY LEU SER ASP ALA ALA GLY ASN GLY SEQRES 9 D 114 PRO GLU GLY VAL ALA ILE SER PHE ASN HIS SEQRES 1 E 114 ALA ALA PRO THR ALA THR VAL THR PRO SER SER GLY LEU SEQRES 2 E 114 SER ASP GLY THR VAL VAL LYS VAL ALA GLY ALA GLY LEU SEQRES 3 E 114 GLN ALA GLY THR ALA TYR TRP VAL TYR GLN ARG ALA ALA SEQRES 4 E 114 VAL ASP THR GLY VAL HIS ALA SER ASN PRO ALA ASP LEU SEQRES 5 E 114 SER SER VAL THR ALA ASP ALA ASN GLY SER ALA SER THR SEQRES 6 E 114 SER LEU THR VAL ARG ARG SER PHE GLU GLY PHE LEU PHE SEQRES 7 E 114 ASP GLY THR ARG TRP GLY THR VAL ASP CYS THR THR ALA SEQRES 8 E 114 ALA CYS GLN VAL GLY LEU SER ASP ALA ALA GLY ASN GLY SEQRES 9 E 114 PRO GLU GLY VAL ALA ILE SER PHE ASN HIS SEQRES 1 F 114 ALA ALA PRO THR ALA THR VAL THR PRO SER SER GLY LEU SEQRES 2 F 114 SER ASP GLY THR VAL VAL LYS VAL ALA GLY ALA GLY LEU SEQRES 3 F 114 GLN ALA GLY THR ALA TYR TRP VAL TYR GLN ARG ALA ALA SEQRES 4 F 114 VAL ASP THR GLY VAL HIS ALA SER ASN PRO ALA ASP LEU SEQRES 5 F 114 SER SER VAL THR ALA ASP ALA ASN GLY SER ALA SER THR SEQRES 6 F 114 SER LEU THR VAL ARG ARG SER PHE GLU GLY PHE LEU PHE SEQRES 7 F 114 ASP GLY THR ARG TRP GLY THR VAL ASP CYS THR THR ALA SEQRES 8 F 114 ALA CYS GLN VAL GLY LEU SER ASP ALA ALA GLY ASN GLY SEQRES 9 F 114 PRO GLU GLY VAL ALA ILE SER PHE ASN HIS
HET SO4 A1113 5 HET SO4 B1115 5 HET SO4 C1114 5 HET SO4 E1114 5 HET SO4 F1113 5 HET TH2 A1114 28 HET TH2 A1115 28 HET TH2 B1116 28 HET TH2 B1117 28 HET TH2 C1115 28 HET TH2 D1114 28 HET TH2 E1115 28 HET TH2 F1114 28
HETNAM SO4 SULFATE ION HETNAM TH2 TESTOSTERONE HEMISUCCINATE
HETSYN TH2 4-OXO-4-{[(8ALPHA,9BETA,10ALPHA,13ALPHA, HETSYN 2 TH2 14BETA,17ALPHA)-3-OXOANDROST-4-EN-17-YL]OXY} HETSYN 3 TH2 BUTANOIC ACID
FORMUL 7 SO4 5(O4 S 2-) FORMUL 12 TH2 8(C23 H32 O5) FORMUL 20 HOH *87(H2 O1)
HELIX 1 1 PRO A 49 LEU A 52 5 4 HELIX 2 2 PRO B 49 LEU B 52 5 4 HELIX 3 3 PRO C 49 LEU C 52 5 4 HELIX 4 4 PRO D 49 LEU D 52 5 4 HELIX 5 5 PRO E 49 LEU E 52 5 4 HELIX 6 6 PRO F 49 LEU F 52 5 4
SHEET 1 AA 3 THR A 4 THR A 8 0 SHEET 2 AA 3 VAL A 18 ALA A 24 -1 O LYS A 20 N THR A 8 SHEET 3 AA 3 ALA A 63 THR A 68 -1 O ALA A 63 N GLY A 23 SHEET 1 AB 4 SER A 53 THR A 56 0 SHEET 2 AB 4 ALA A 31 ASP A 41 -1 O TYR A 32 N VAL A 55 SHEET 3 AB 4 GLN A 94 SER A 98 -1 O GLN A 94 N ARG A 37 SHEET 4 AB 4 VAL A 108 ALA A 109 -1 O VAL A 108 N VAL A 95 SHEET 1 AC 5 SER A 53 THR A 56 0 SHEET 2 AC 5 ALA A 31 ASP A 41 -1 O TYR A 32 N VAL A 55 SHEET 3 AC 5 VAL A 44 SER A 47 -1 O VAL A 44 N ASP A 41 SHEET 4 AC 5 SER A 72 LEU A 77 -1 O PHE A 76 N SER A 47 SHEET 5 AC 5 ARG A 82 ASP A 87 -1 N TRP A 83 O GLY A 75 SHEET 1 BA 3 THR B 4 THR B 8 0 SHEET 2 BA 3 VAL B 18 ALA B 24 -1 O LYS B 20 N THR B 8 SHEET 3 BA 3 ALA B 63 THR B 68 -1 O ALA B 63 N GLY B 23 SHEET 1 BB 3 VAL B 44 SER B 47 0 SHEET 2 BB 3 ALA B 31 ASP B 41 -1 O ALA B 38 N ALA B 46 SHEET 3 BB 3 SER B 53 THR B 56 -1 O SER B 53 N VAL B 34 SHEET 1 BC 4 VAL B 44 SER B 47 0 SHEET 2 BC 4 ALA B 31 ASP B 41 -1 O ALA B 38 N ALA B 46 SHEET 3 BC 4 CYS B 93 SER B 98 -1 O GLN B 94 N ARG B 37 SHEET 4 BC 4 VAL B 108 ALA B 109 -1 O VAL B 108 N VAL B 95 SHEET 1 BD 2 SER B 72 PHE B 76 0 SHEET 2 BD 2 ARG B 82 ASP B 87 -1 N TRP B 83 O GLY B 75 SHEET 1 CA 3 THR C 4 THR C 8 0 SHEET 2 CA 3 VAL C 18 ALA C 24 -1 O LYS C 20 N THR C 8 SHEET 3 CA 3 ALA C 63 THR C 68 -1 O ALA C 63 N GLY C 23 SHEET 1 CB 4 SER C 53 THR C 56 0 SHEET 2 CB 4 ALA C 31 ASP C 41 -1 O TYR C 32 N VAL C 55 SHEET 3 CB 4 CYS C 93 SER C 98 -1 O GLN C 94 N ARG C 37 SHEET 4 CB 4 VAL C 108 ALA C 109 -1 O VAL C 108 N VAL C 95 SHEET 1 CC 5 SER C 53 THR C 56 0 SHEET 2 CC 5 ALA C 31 ASP C 41 -1 O TYR C 32 N VAL C 55 SHEET 3 CC 5 VAL C 44 SER C 47 -1 O VAL C 44 N VAL C 40 SHEET 4 CC 5 SER C 72 LEU C 77 -1 O PHE C 76 N SER C 47 SHEET 5 CC 5 ARG C 82 ASP C 87 -1 N TRP C 83 O GLY C 75 SHEET 1 DA 3 THR D 4 THR D 8 0 SHEET 2 DA 3 VAL D 18 ALA D 24 -1 O LYS D 20 N THR D 8 SHEET 3 DA 3 ALA D 63 THR D 68 -1 O ALA D 63 N GLY D 23 SHEET 1 DB 9 SER D 53 THR D 56 0 SHEET 2 DB 9 ALA D 31 ASP D 41 -1 O TYR D 32 N VAL D 55 SHEET 3 DB 9 ARG D 82 ASP D 87 SHEET 4 DB 9 SER D 72 LEU D 77 -1 O PHE D 73 N VAL D 86 SHEET 5 DB 9 VAL D 44 SER D 47 -1 O SER D 47 N PHE D 76 SHEET 6 DB 9 ALA D 31 ASP D 41 -1 O ALA D 38 N ALA D 46 SHEET 7 DB 9 VAL D 108 ALA D 109 SHEET 8 DB 9 CYS D 93 SER D 98 -1 O VAL D 95 N VAL D 108 SHEET 9 DB 9 ALA D 31 ASP D 41 -1 O TRP D 33 N SER D 98 SHEET 1 EA 3 THR E 4 THR E 8 0 SHEET 2 EA 3 VAL E 18 ALA E 24 -1 O LYS E 20 N THR E 8 SHEET 3 EA 3 ALA E 63 THR E 68 -1 O ALA E 63 N GLY E 23 SHEET 1 EB 9 SER E 53 THR E 56 0 SHEET 2 EB 9 ALA E 31 ASP E 41 -1 O TYR E 32 N VAL E 55 SHEET 3 EB 9 ARG E 82 ASP E 87 SHEET 4 EB 9 SER E 72 LEU E 77 -1 O PHE E 73 N VAL E 86 SHEET 5 EB 9 VAL E 44 SER E 47 -1 O SER E 47 N PHE E 76 SHEET 6 EB 9 ALA E 31 ASP E 41 -1 O ALA E 38 N ALA E 46 SHEET 7 EB 9 VAL E 108 ALA E 109 SHEET 8 EB 9 CYS E 93 SER E 98 -1 O VAL E 95 N VAL E 108 SHEET 9 EB 9 ALA E 31 ASP E 41 -1 O TRP E 33 N SER E 98 SHEET 1 FA 3 THR F 4 THR F 8 0 SHEET 2 FA 3 VAL F 18 ALA F 24 -1 O LYS F 20 N THR F 8 SHEET 3 FA 3 SER F 62 THR F 68 -1 O ALA F 63 N GLY F 23 SHEET 1 FB 7 VAL F 44 SER F 47 0 SHEET 2 FB 7 ALA F 31 ASP F 41 -1 O ALA F 38 N ALA F 46 SHEET 3 FB 7 SER F 53 THR F 56 -1 O SER F 53 N VAL F 34 SHEET 4 FB 7 ALA F 31 ASP F 41 -1 O TYR F 32 N VAL F 55 SHEET 5 FB 7 VAL F 108 ALA F 109 SHEET 6 FB 7 CYS F 93 SER F 98 -1 O VAL F 95 N VAL F 108 SHEET 7 FB 7 ALA F 31 ASP F 41 -1 O TRP F 33 N SER F 98 SHEET 1 FC 2 SER F 72 PHE F 76 0 SHEET 2 FC 2 ARG F 82 ASP F 87 -1 N TRP F 83 O GLY F 75
SSBOND 1 CYS A 88 CYS A 93 1555 1555 2.03 SSBOND 2 CYS B 88 CYS B 93 1555 1555 2.03 SSBOND 3 CYS C 88 CYS C 93 1555 1555 2.03 SSBOND 4 CYS D 88 CYS D 93 1555 1555 2.03 SSBOND 5 CYS E 88 CYS E 93 1555 1555 2.03 SSBOND 6 CYS F 88 CYS F 93 1555 1555 2.02
CISPEP 1 THR A 8 PRO A 9 0 -0.47 CISPEP 2 THR B 8 PRO B 9 0 -0.33 CISPEP 3 THR C 8 PRO C 9 0 -0.57 CISPEP 4 THR D 8 PRO D 9 0 -0.25 CISPEP 5 THR E 8 PRO E 9 0 -0.12 CISPEP 6 THR F 8 PRO F 9 0 -0.17
SITE 1 AC1 3 SER A 14 ASP A 15 ARG A 71 SITE 1 AC2 3 ASP B 15 ARG B 71 ASN B 113 SITE 1 AC3 4 SER C 14 ASP C 15 ARG C 71 ASN C 113 SITE 1 AC4 3 SER E 14 ASP E 15 ARG E 71 SITE 1 AC5 3 SER F 14 ASP F 15 ARG F 71 SITE 1 AC6 7 TRP A 33 TYR A 35 SER A 47 PRO A 49 SITE 2 AC6 7 ALA A 101 GLY A 102 TRP C 33 SITE 1 AC7 8 TRP A 83 VAL A 86 ASP A 87 THR A 90 SITE 2 AC7 8 ALA A 91 THR F 8 VAL F 18 LYS F 20 SITE 1 AC8 8 THR B 8 TRP B 33 TYR B 35 SER B 47 SITE 2 AC8 8 PRO B 49 ALA B 100 ALA B 101 GLY B 102 SITE 1 AC9 11 TRP B 83 VAL B 86 ASP B 87 THR B 90 SITE 2 AC9 11 ALA B 91 THR C 8 VAL C 18 LYS C 20 SITE 3 AC9 11 GLY E 43 HIS E 45 PHE E 78 SITE 1 BC1 9 HOH A2010 TRP C 33 TYR C 35 SER C 47 SITE 2 BC1 9 PRO C 49 SER C 98 ALA C 101 GLY C 102 SITE 3 BC1 9 SER D 11 SITE 1 BC2 7 TRP D 33 TYR D 35 SER D 47 PRO D 49 SITE 2 BC2 7 SER D 98 GLY D 102 TH2 E1115 SITE 1 BC3 9 SER C 11 TH2 D1114 TRP E 33 SER E 47 SITE 2 BC3 9 PRO E 49 LEU E 52 PHE E 78 ALA E 100 SITE 3 BC3 9 GLY E 102 SITE 1 BC4 5 TRP F 33 TYR F 35 SER F 47 PRO F 49 SITE 2 BC4 5 ALA F 100
CRYST1 52.976 97.827 129.268 90.00 90.00 90.00 P 21 21 21 24
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.018876 0.000000 0.000000 0.00000
SCALE2 0.000000 0.010222 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007736 0.00000